Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin to Protect Renal Function After Cardiac Surgery
NCT01423955Phase 2Completed
- Sponsor
- Region Skåne
- Start
- Oct 2011
- Primary completion
- Jan 2013
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa or beta in acute kidney injury (AKI), sponsored by Region Skåne. Started Oct 2011; status: completed.
02
Drugs
epoetin alfa or beta
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01423955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01423955.